Ausgabe 2/2018
Inhalt (9 Artikel)
Expanding Capacity to Treat Hepatitis C: Overcoming Barriers and New Innovations
Joseph K. Lim
Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis
Barbara Lattanzi, Daria D’Ambrosio, Veronica Fedele, Manuela Merli
The Newest Direct-Acting Antiviral Agents: the Final Chapter in DAA Development
Marwa Ismail, Jordan J. Feld
Hepatitis C Virus Treatment in Non-Liver Organ Transplantation Programs
Eduardo A. Rodriguez, Bashar A. Aqel
Strategies for the Elimination of Hepatitis C Virus Infection as a Public Health Threat in the United States
Charitha Gowda, Vincent Lo Re III
Treatment of DAA-Experienced Patients with Chronic Hepatitis C
Maria A. Corcorran, John D. Scott
Extrahepatic Malignancies in Primary Biliary Cholangitis
Annarosa Floreani, Maria Francesca Secchi
Ethnic and Racial Differences in Autoimmune Liver Diseases
Arnaldo Freire, Cynthia Levy
Therapeutics for Pruritus in Cholestatic Liver Disease: Many Treatments but Few Cures
Mark Pederson, Marlyn J. Mayo